— Know what they know.
Not Investment Advice

CYDY OTC

CytoDyn Inc.
1W: -11.9% 1M: -4.3% 3M: -15.0% YTD: -25.9% 1Y: -23.0% 3Y: +14.2% 5Y: -91.4%
$0.20
+0.00 (+0.50%)
 
Weekly Expected Move ±8.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 39 · $273.9M mcap · 1.37B float · 0.126% daily turnover · Short 40% of daily vol

Balance Sheet Trends

Total Assets
$14M -22.6% ▼
5Y CAGR: -36.2%
Total Liabilities
$124M +8.4% ▲
5Y CAGR: -4.2%
Shareholders Equity
-$110M -14.2% ▼
Cash & Investments
$12M -0.4% ▼
5Y CAGR: -19.0%
Total Debt
$38M +40.2% ▲
5Y CAGR: -9.6%
Net Debt
$26M +71.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$4M$3M$3M$12M$12M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$4M$3M$3M$12M$12M
Net Receivables$0$0$0$2M$0
Inventory$18M$0$0$0$0
Other Current Assets$0$7M$7M$0$0
Total Current Assets$28M$11M$11M$18M$14M
Property, Plant & Equip.$609K$400K$264K$0$0
Goodwill & Intangibles$132K$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$87K$57K$169K$95K
Total Non-Current Assets$741K$487K$321K$169K$95K
Total Assets$29M$11M$11M$18M$14M
— Liabilities —
Accounts Payable$68M$63M$30M$15M$13M
Short-Term Debt$36M$34M$30M$27M$12M
Deferred Revenue$0$23M$0$0$0
Other Current Liabilities$4M$22M$7M$423K$19M
Total Current Liabilities$123M$120M$84M$71M$54M
Long-Term Debt$0$714K$0$0$26M
Other Non-Current Liab.$0$0$44M$44M$44M
Total Non-Current Liabilities$422K$997K$44M$44M$70M
Total Liabilities$124M$121M$128M$114M$124M
— Equity —
Common Stock$720K$919K$1M$1M$1M
Retained Earnings-$766M-$842M-$892M-$888M-$930M
Accumulated OCI$0$0-$7M$0$0
Total Stockholders Equity-$94M-$110M-$117M-$96M-$110M
Total Liabilities & Equity$29M$11M$11M$18M$14M
— Key Metrics —
Total Debt$37M$35M$30M$27M$38M
Net Debt$33M$33M$27M$15M$26M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms